Free Newsletter
EU wholesalers concerned about packaging
The European Commission recently released its "pharmaceutical package," which has some anti-counterfeiting proposals that the European Association of Pharmaceutical Full-line Wholesalers (GIRP) finds troubling. While GIRP was pleased with new legislation to prevent some medications from entering into the legal supply chain, it raised concerns about the number of licenses that distributors across the European Union received. Report.
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: